S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ENSC Ensysce Biosciences Inc

2.89

-0.40 (-12.16%)

Apr 28 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Ensysce Biosciences (NASDAQ:ENSC)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Ensysce Biosciences Charts.

Ensysce Biosciences (NASDAQ:ENSC)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Ensysce Biosciences Charts.

Ensysce Biosciences Inc News

Form EFFECT - Notice of Effectiveness
Thursday 24 April 2025 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 24 April 2025 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 1 April 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 31 March 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 31 March 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Monday 10 March 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 10 March 2025 (2 months ago) • Edgar (US Regulatory)

Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation Opioids
Monday 3 March 2025 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 4 February 2025 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 3 December 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 21 November 2024 (5 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 19 November 2024 (5 months ago) • Edgar (US Regulatory)

More Ensysce Biosciences Inc News Articles

Graniteshares 3xshort Al...

Xtrackers Future Mobilit...

Invesco EQQQ NASDAQ-100 ...

Tabula Us Enhanced Infla...

Xtrackers Esg Usd Emergi...

Global X Fintech UCITS E...

BNP Paribas Issuance

Exchange Traded Fund Ivz...

Xtrackers MSCI USA Infor...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions